logo-loader
RNS
viewGlaxoSmithKline PLC

GlaxoSmithKline PLC - Total Voting Rights

RNS Number : 9751A
GlaxoSmithKline PLC
03 June 2019
 

GlaxoSmithKline plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 31 May 2019 consisted of 5,381,466,396 shares of 25 pence each ('Ordinary Shares'), of which 393,505,950 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,987,960,446. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

 

V A Whyte

Company Secretary

 

3 June 2019

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRUGURPQUPBGWW

Quick facts: GlaxoSmithKline PLC

Price: 1625.8

Market: LSE
Market Cap: £81.57 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE